Scarica l'app Stockscreener
4.38
3.06%
0.13
Dopo l'orario di chiusura:
4.26
-0.12
-2.74%
Precedente Chiudi:
$4.25
Aprire:
$4.33
Volume 24 ore:
1.41M
Relative Volume:
1.18
Capitalizzazione di mercato:
$209.12M
Reddito:
-
Utile/perdita netta:
$-64.20M
Rapporto P/E:
-2.0372
EPS:
-2.15
Flusso di cassa netto:
$57,000
1 W Prestazione:
+90.43%
1M Prestazione:
+129.32%
6M Prestazione:
+256.10%
1 anno Prestazione:
+116.30%
Intervallo 1D:
$4.04
$4.60
Intervallo di 1 settimana:
$2.30
$4.82
Portata 52W:
$1.05
$4.82
Climb Bio Inc Stock (CLYM) Company Profile
Nome
Climb Bio Inc
Settore
Industria
Telefono
1-866-857-2596
Indirizzo
20 WILLIAM STREET, WELLESLEY HILLS
Confronta CLYM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
4.38 | 202.91M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-16 | Iniziato | William Blair | Outperform |
| 2025-10-13 | Iniziato | H.C. Wainwright | Buy |
| 2025-08-15 | Iniziato | Robert W. Baird | Outperform |
| 2025-06-06 | Iniziato | Oppenheimer | Outperform |
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Climb Bio Inc Borsa (CLYM) Ultime notizie
Pre Market Movers: ALGS, PDSB, PCSA Swing Big - RTTNews
H.C. Wainwright raises Climb Bio stock price target to $11 on budoprutug progress - Investing.com
Climb Bio price target raised to $11 from $9 at H.C. Wainwright - TipRanks
Climb Bio, Inc. (NASDAQ:CLYM) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Ra Capital Management, L.P. Buys 101,462 Shares of Climb Bio (NASDAQ:CLYM) Stock - Defense World
Climb Bio Stock 7-Day Winning Spree: Stock Climbs 169% - Trefis
Climb Bio Soars Amid Strategic Move and Market Optimism - timothysykes.com
Monday’s Insider Moves: Prairie Operating Owner Leads Buying Spree - Investing.com
Climb Bio (NASDAQ:CLYM) Director Ra Capital Management, L.P. Purchases 213,099 Shares - Defense World
Climb bio sees $754k in purchases from RA Capital funds By Investing.com - Investing.com South Africa
Climb Bio Stock Rockets 122% With 6-Day Winning Streak - Trefis
Ra Capital Management, L.P. Buys 213,099 Shares of Climb Bio (NASDAQ:CLYM) Stock - MarketBeat
Insider Buying: Climb Bio (NASDAQ:CLYM) Director Buys 101,462 Shares of Stock - MarketBeat
Climb bio sees $754k in purchases from RA Capital funds - Investing.com
Data-Rich Year AheadWill 2026 Readouts Lift Climb Bio Higher - RTTNews
Aug Highlights: Is Climb Bio Inc. stock a safe investment in uncertain marketsJuly 2025 Selloffs & Daily Profit Maximizing Tips - moha.gov.vn
Patterns Watch: How strong is Climb Bio Inc stock balance sheetWeekly Trade Recap & Capital Protection Trading Alerts - moha.gov.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Climb Bio Enters Exchange Agreement with RA Capital - TipRanks
There is no doubt that Climb Bio Inc (CLYM) ticks all the boxes. - setenews.com
Stocks of Korro Bio Inc (KRRO) are poised to climb above their peers - setenews.com
Stocks of Upstream Bio Inc (UPB) are poised to climb above their peers - setenews.com
Can Climb Bio Inc. stock withstand economic slowdown2025 Dividend Review & Risk Managed Investment Strategies - Newser
Is Climb Bio Inc. stock a safe investment in uncertain marketsTrade Entry Report & Low Risk Investment Opportunities - moha.gov.vn
Stocks of Petco Health and Wellness Co Inc (WOOF) are poised to climb above their peers - setenews.com
Climb Bio, Inc. (CLYM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Climb Bio reports inducement grant under Nasdaq listing rule - MSN
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - markets.businessinsider.com
Brokerages Set Climb Bio, Inc. (NASDAQ:CLYM) Price Target at $9.20 - Defense World
Climb Bio (Nasdaq: CLYM) Announces Inducement Option for 120K Shares - Stock Titan
Climb Bio Inc (CLYM) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Published on: 2025-11-19 22:13:39 - newser.com
Is Climb Bio Inc. stock a buy on dipsMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
How sustainable is Climb Bio Inc. stock dividend payoutWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Is Climb Bio Inc. stock attractive after correctionQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Why Climb Bio Inc. stock is recommended by analystsInsider Selling & Accurate Buy Signal Alerts - newser.com
Predicting Climb Bio Inc. trend using moving averages2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Strategies to average down on Climb Bio Inc.2025 Big Picture & Capital Efficiency Focused Ideas - newser.com
Will Climb Bio Inc. stock go up soonRate Cut & High Win Rate Trade Tips - newser.com
Visualizing Climb Bio Inc. stock with heatmapsForecast Cut & Stock Market Timing Techniques - newser.com
Momentum divergence signals in Climb Bio Inc. chart2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
Stocks of ECARX Holdings Inc (ECX) are poised to climb above their peers - setenews.com
Has Climb Bio Inc. formed a bullish divergence2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Using R and stats models for Climb Bio Inc. forecastingJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
Climb Bio Inc Azioni (CLYM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):